BioDuro launches AI-driven COVID-19 nanobody therapeutic program
BioDuro said that it has launched a COVID-19 nanobody therapeutic program by leveraging its biologics discovery platform, which makes use of artificial intelligence computing and high-speed DNA mutagenesis technology. The life sciences contract research and development organization expects to screen over 10 billion human synthetic antibodies generated by its technology platform. BioDuro said that its […]